A nurse is assessing a client who has received oxycodone. The nurse notes that the client's respiratory rate is 8/min. The nurse should identify that which of the following is the pathophysiology for the client's respiratory rate?
Oxycodone blocks the sodium channel suspending nerve conduction.
Oxycodone inhibits prostaglandin synthesis.
Oxycodone promotes vasodilation of cranial arteries.
Oxycodone uses central nervous system depression.
The Correct Answer is D
A. Oxycodone primarily exerts its analgesic effects through binding to opioid receptors and modulating neurotransmitter release, rather than blocking sodium channels.
B. Oxycodone does not directly inhibit prostaglandin synthesis; this mechanism is associated with nonsteroidal anti-inflammatory drugs (NSAIDs).
C. Oxycodone does not promote vasodilation of cranial arteries. This mechanism is more commonly associated with medications used to treat migraines, such as triptans.
D. Oxycodone is an opioid analgesic that acts centrally on the nervous system to depress respiratory drive, leading to respiratory depression, especially at higher doses.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
A. Oxycodone, like other opioid medications, can cause constipation, so advising the client to take a stool softener can help prevent or alleviate this common side effect.
B. Urinary frequency is not a common side effect of oxycodone.
C. There is no known association between oxycodone and sunlight exposure, so advising the client to minimize sunlight exposure is unnecessary.
D. Oxycodone can be taken with or without food, so there is no requirement to take it on an empty stomach.
Correct Answer is C
Explanation
A. Laryngospasm: Laryngospasm is not a commonly associated adverse effect of alteplase administration. It is more commonly associated with airway irritants or allergic reactions.
B. Polycythemia: Polycythemia, or an abnormally high red blood cell count, is not a typical adverse effect of alteplase administration. Alteplase is a thrombolytic agent used to dissolve blood clots and is not associated with increasing red blood cell production.
C. Hemorrhage: Hemorrhage, or bleeding, is the most significant adverse effect associated with alteplase administration. Alteplase works by promoting fibrinolysis and can increase the risk of bleeding, including intracranial hemorrhage, particularly in the context of thrombolytic therapy for stroke.
D. Steatorrhea: Steatorrhea, or fatty stools, is not a commonly associated adverse effect of alteplase administration. It is more commonly associated with malabsorption disorders or pancreatic insufficiency.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.